Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

104.39 +0.76 (+0.73%)
Streaming Delayed Price Updated: 11:32 AM EST, Nov 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:... 
Via Benzinga
Exposures COVID-19
This Smart Monitor Company Has Outperformed Apple, Google And Amazon Over The Last 5 Years
A smart monitor company that received FDA approval in 2015 has seen a five-year stock performance that has outperformed the returns of Apple Inc (NASDAQ: AAPL), Alphabet Inc (... 
Via Benzinga
Exposures Product Safety
Where Abbott Laboratories Stands With Analysts
Within the last quarter, Abbott Laboratories (NYSE:ABT) has ... 
Via Benzinga
Podcast: How to Find STEM Success? Learn to Pivot.
SOURCE: Abbott 
Via 3BL Media
A Workplace Where Collaboration = Innovation
SOURCE: Abbott 
Via 3BL Media
Exposures COVID-19
Abbott Labs Stock Strength Rises Into New Percentile As Health Care Giant Expands Organically And Via Acquisition
Additionally, Chicago-based Abbott Labs stock carries a near-perfect 98 Composite Rating, putting it in the top 2% of all stocks. 
Via Investor's Business Daily
Shares Of Abbott Laboratories (ABT) Rise Above Previous 52-Week High
Abbott Laboratories (NYSE: ABT) traded today at a new 52-week high of $129.40. Approximately 642,000 shares have changed hands today, as compared to an average 30-day volume of 4.... 
Via Benzinga
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:... 
Via Benzinga
Where Abbott Laboratories Stands With Analysts
Analysts have provided the following ratings for Abbott Laboratories (NYSE: 
Via Benzinga
Why Shares of Quidel Surged 10% This Week
Demand for its COVID tests are rising with cases. 
Via The Motley Fool
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... 
Via Benzinga
This May Be Abbott's Billion-Dollar Opportunity
Abbott delivered bad news back in June. But the tide has turned. 
Via The Motley Fool
Exposures COVID-19
Abbott Says Amulet Superior To Boston Scientific's Watchman In Stroke Study
Abbott Laboratories (NYSE: ABT) has announced late-breaking data from the Amulet LAA Occluder IDE trial. The head-to-head study compared Abbott's Amplatzer... 
Via Benzinga
See Why CVS Is Limiting Purchase Of OTC COVID-19 Tests
CVS Health Corp (NYSE: CVS) is capping purchases of rapid, over-the-counter COVID-19 tests, with a maximum of six packages available online and four in its pharmacies. The... 
Via Benzinga
Exposures COVID-19
Healthcare Stocks Hit New Highs but Small Caps Lag
Many smaller cap biotech stocks trade on news and milestones and have no earnings so require more expertise in the field. 
Via Talk Markets
Abbott Destroyed Several COVID Test Cards, Now Faces Diminished Capacity: NYT
When demand for rapid COVID-19 screening dropped earlier this year, Abbott Laboratories (NYSE: ABT) lowered its financial outlook for full-year 2021 and ... 
Via Benzinga
Exposures COVID-19
NeuroSphere Virtual Clinic Brings Relief to Rural Town
SOURCE: Abbott 
Via 3BL Media
Exposures Lead
AbbVie: Dividend Stock to Buy?!
The quest to find undervalued dividend stocks to buy in this hot stock market continues. The S&P 500 continues to trend higher and set record highs, even though we’ve had a few down days recently. 
Via Talk Markets
Topics Stocks
Exposures US Equities
FDA Approves Abbott's Atrial Fibrillation Device For LAA Occlusion
The 
Via Benzinga
Exposures Product Safety
Abbott's Freestyle® Libre 2 IOS App Cleared In U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management
SOURCE: Abbott 
Via 3BL Media
Exposures Product Safety
How Spinoffs Affect Your Stocks
When stocks you own spins off a segment or division of its business, the company you own changes. This can change not only the future prospects of the company you own but also its historical... 
Via Talk Markets
2 Stocks That Could Turn $200,000 Into $1,000,000 in 10 Years
Both of these companies know something about beating the market. 
Via The Motley Fool
1 Healthcare Dividend Giant to Bank On Right Now
The pipeline and consistent dividend history of this Dividend Aristocrat mean its payout is likely to remain strong. 
Via The Motley Fool
A Convergence of Challenges: Addressing the Devastating Impact of Chronic Disease on Communities in Crisis
SOURCE: Abbott 
Via 3BL Media
Topics Death
Exposures Death
Innovators in Pharma Sectors See Potential, Promise in Providing Improved Treatments
Via FinancialNewsMedia
Moderna’s (MRNA) Massive Market Cap
As could have been expected in the midst of a global pandemic, one of the most rapidly growing companies has been vaccine producer Moderna. 
Via Talk Markets
Got $5,000? Buy and Hold These 3 Market-Beating Stocks
They're likely to continue to outperform the market. 
Via The Motley Fool
Broader Access is Vital to the Future of Testing and Healthcare Innovation
SOURCE: Abbott 
Via 3BL Media
Exposures COVID-19
Analyzing Abbott Laboratories's Unusual Options Activity
Shares of Abbott Laboratories (NYSE:ABT) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved up to $120.62. Sentiment:... 
Via Benzinga
Understanding Abbott Laboratories's Unusual Options Activity
On Friday, shares of Abbott Laboratories (NYSE:ABT) saw unusual options activity. After the option alert, the stock price moved up to $120.16. Sentiment: BULLISH Option Type:... 
Via Benzinga
< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.